apo-eletriptan tablet
apotex inc - eletriptan (eletriptan hydrobromide) - tablet - 40mg - eletriptan (eletriptan hydrobromide) 40mg - selective serotonin agonists
teva-efavirenz/emtricitabine/tenofovir tablet
teva canada limited - efavirenz; emtricitabine; tenofovir disoproxil fumarate - tablet - 600mg; 200mg; 300mg - efavirenz 600mg; emtricitabine 200mg; tenofovir disoproxil fumarate 300mg - nonnucleoside reverse transcriptase inhibitors
pat-darunavir tablet
patriot a division of janssen inc - darunavir (darunavir ethanolate) - tablet - 150mg - darunavir (darunavir ethanolate) 150mg - hiv protease inhibitors
pat-darunavir tablet
patriot a division of janssen inc - darunavir (darunavir ethanolate) - tablet - 75mg - darunavir (darunavir ethanolate) 75mg - hiv protease inhibitors
pat-darunavir tablet
patriot a division of janssen inc - darunavir (darunavir ethanolate) - tablet - 400mg - darunavir (darunavir ethanolate) 400mg - hiv protease inhibitors
pat-darunavir tablet
patriot a division of janssen inc - darunavir (darunavir ethanolate) - tablet - 600mg - darunavir (darunavir ethanolate) 600mg - hiv protease inhibitors
pat-darunavir tablet
patriot a division of janssen inc - darunavir (darunavir ethanolate) - tablet - 800mg - darunavir (darunavir ethanolate) 800mg - hiv protease inhibitors
mylan-efavirenz/emtricitabine/tenofovir disoproxil fumarate tablet
mylan pharmaceuticals ulc - efavirenz; emtricitabine; tenofovir disoproxil fumarate - tablet - 600mg; 200mg; 300mg - efavirenz 600mg; emtricitabine 200mg; tenofovir disoproxil fumarate 300mg - nonnucleoside reverse transcriptase inhibitors
apo-efavirenz-emtricitabine-tenofovir tablet
apotex inc - efavirenz; emtricitabine; tenofovir disoproxil fumarate - tablet - 600mg; 200mg; 300mg - efavirenz 600mg; emtricitabine 200mg; tenofovir disoproxil fumarate 300mg - nonnucleoside reverse transcriptase inhibitors
eletriptan hydrobromide tablet, film coated
zydus lifesciences limited - eletriptan hydrobromide (unii: m41w832ta3) (eletriptan - unii:22qoo9b8ki) - eletriptan 20 mg - eletriptan hydrobromide tablets are indicated for the acute treatment of migraine with or without aura in adults. limitations of use: - use only if a clear diagnosis of migraine has been established. if a patient has no response to the first migraine attack treated with eletriptan hydrobromide, reconsider the diagnosis of migraine before eletriptan hydrobromideis administered to treat any subsequent attacks. - eletriptan hydrobromidetablets arenot intended for the prevention of migraine attacks. - safety and effectiveness of eletriptan hydrobromidehave not been established for cluster headache. eletriptan hydrobromide is contraindicated in patients with: - ischemic coronary artery disease (cad) (angina pectoris, history of myocardial infarction, or documented silent ischemia) or coronary artery vasospasm, including prinzmetal's angina [see warnings and precautions (5.1)]. - wolff-parkinson-white syndrome or arrhythmias associated with other cardiac accessory conduction pathway disorde